[Acquired cystic kidney disease-associated renal cell carcinoma: a clinicopathologic study of three cases]

Zhonghua Bing Li Xue Za Zhi. 2018 May 8;47(5):366-371. doi: 10.3760/cma.j.issn.0529-5807.2018.05.010.
[Article in Chinese]

Abstract

Objective: To study the clinicopathologic, immunohistochemical (IHC), histogenetic and prognostic features of acquired cystic kidney disease-associated renal cell carcinoma (ACKD-RCC). Methods: Three cases of ACKD-RCC, including two from 401 Hospital of PLA and one from the Affiliated Hospital of Qingdao University were studied by clinical, histological and IHC analysis with review of relevant literature. Results: All the three patients were male, ranging from 46 to 78 years old. All patients had history of chronic renal failure; two patients were treated with hemodialysis for 9 years and 11 years, respectively. In two cases the tumor sizes were 2.5 cm and 3.5 cm, respectively, and the tumor border was distinct. The remaining case showed extensive renal hemorrhage with an inconspicuous mass. Microscopically, the tumor cells were arranged in cribriform, microcystic or acinar structures, with variable papillary structure in one case. Hemorrhage of varying degrees was seen in all three cases, and obvious necrosis was noted in two. The tumor cells had deeply eosinophilic cytoplasm, indistinct cell border, round or oval nuclei, and prominent nucleoli (WHO/ISUP grade 3). Mitoses were rare. Abundant oxalate crystals were seen in two cases. The renal mesenchyme of all three cases were atrophic with variable cystic changes of the renal tubules, the lining cells showed atypical hyperplasia. IHC staining showed all tumors were diffusely positive for vimentin, CD10, RCC, CAM5.2, P504s and mitochondria in the cytoplasm, and were variably positive for EMA (2/3), CK7 (1/3), CA9 (1/3) and PAX8 (3/3). All cases were negative for CD117, HMB45, Melan A and TFE3. After 3-14 months follow-up, one patient died from renal failure six months after surgery. The other two patients were alive without tumor recurrence or metastasis. Conclusions: ACKD-RCC is a very rare renal cell carcinoma. The specific cribriform structure, deeply eosinophilic cytoplasm, prominent nucleoli (WHO/ISUP grade 3), and oxalate crystals deposition, associated with the history of ACKD could aid the diagnosis. ACKD-RCC arises from the proximal renal tubule and its histogenesis might be associated with proliferation and malignant change of the atypical epithelial cells of the cystic renal tubules. ACKD-RCC may have a favorable prognosis except for tumors with sarcomatoid differentiation.

目的: 探讨获得性囊性肾病相关性肾细胞癌(acquired cystic kidney disease-associated renal cell carcinoma,ACKD-RCC)的临床病理特点、免疫表型、组织发生及预后。 方法: 收集2010年至2017年解放军第四一医院2例和青岛大学附属医院1例ACKD-RCC患者的临床资料,进行组织形态学观察和免疫组织化学分析,并复习相关文献。 结果: 3例均为男性,年龄46~78岁,均有慢性肾功能衰竭病史,2例曾行血液透析分别9年和11年。大体上2例瘤组织边界清楚,直径2.5和3.5 cm,1例肾脏广泛出血,肿瘤不明显。镜下观察:瘤组织主要呈筛状、微囊状或腺泡状排列,1例局部可见多量乳头状结构,3例均有程度不等的出血,2例坏死明显,瘤细胞胞质丰富、嗜酸性,边界不清,核圆形或椭圆形,核仁明显[WHO/国际泌尿病理协会(ISUP)核分级3级],核分裂象少见,2例肿瘤内可见多量草酸盐结晶。3例肿瘤周围肾实质均显示萎缩,肾小管不同程度囊状扩张,部分衬覆异型增生的肾小管上皮细胞。免疫组织化学染色:3例肿瘤均弥漫强阳性表达CD10、肾细胞癌标志物(RCC)、P504s、波形蛋白、CAM5.2和mitochondria;上皮细胞膜抗原(EMA,2/3)、细胞角蛋白7(CK7,1/3)、碳酸酐酶Ⅸ(CA9,1/3)和PAX8(3/3)等不同程度表达;而CD117、HMB45、Melan A和TFE3均阴性。3例随访3~14个月,除1例术后6个月死于肾功能衰竭外,另2例均存活,无复发和转移。 结论: ACKD-RCC是一种非常少见的肾细胞癌,依据患者有ACKD的病史以及形态学上独特的筛状结构、胞质嗜酸性、核仁明显(WHO/ISUP核分级3级)的癌细胞以及癌组织内出现特征性的草酸盐结晶沉积,可明确诊断。该肿瘤组织起源于肾近段小管,其发生可能与ACKD不典型囊肿上皮细胞增生癌变有关,其生物学行为大多属低度恶性,但有肉瘤样分化时预后较差。.

Keywords: Diagnosis, differential; Immunohistochemistry; Prognosis; Renal cell carcinoma.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Carcinoma, Renal Cell / chemistry
  • Carcinoma, Renal Cell / pathology*
  • Humans
  • Immunohistochemistry
  • Kidney Diseases, Cystic / pathology*
  • Kidney Neoplasms / chemistry
  • Kidney Neoplasms / pathology*
  • Kidney Tubules / pathology
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Neprilysin / analysis
  • Prognosis
  • Racemases and Epimerases / analysis
  • Tumor Burden
  • Vimentin / analysis

Substances

  • Vimentin
  • Neprilysin
  • Racemases and Epimerases
  • alpha-methylacyl-CoA racemase